spacer
The Healthcare Sales & Marketing Network celebrates 21 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  orally disintegrating tablet 

 HSMN NewsFeed - 4 Dec 2018
Mylan Expands Gastroenterology Portfolio with Launch of Generic for Prevacid(R) SoluTab Delayed-Release Orally Disintegrating Tablets
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 27 Aug 2018
Tris Pharma Announces Hiring of New Vice President of Quality & Compliance
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 10 Jul 2018
Sandoz Inc. and its affiliate, Novartis Pharmaceuticals Corporation, voluntarily recall select blister packages of products in the U.S. due to packaging requirements for child resistance
Biopharmaceuticals Product Recall
 HSMN NewsFeed - 16 May 2016
Neos Therapeutics Announces U.S. Launch of Adzenys XR-ODT(TM) (Amphetamine Extended-Release Orally Disintegrating Tablet) for the Treatment of ADHD in Patients Six Years and Older
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 28 Jan 2016
Neos Therapeutics Announces FDA Approval of Adzenys XR-ODT(TM) (Amphetamine Extended-Release Orally Disintegrating Tablet) for the Treatment of ADHD in Patients 6 Years and Older
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 29 Jul 2015
Galena Biopharma Launches Zuplenz(R) (ondansetron) Oral Soluble Film
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 7 Oct 2014
Pinnacle Biologics, Inc., a subsidiary of Concordia Healthcare Corp., announces European site initiation of Phase 3 bile duct cancer trial using photodynamic therapy with PHOTOFRIN(R)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Sep 2014
Eisai Sells U.S. Rights to Zonegran(R) (zonisamide) Capsules to Concordia Pharmaceuticals Inc.
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 26 Mar 2014
FDA Approves Optiguide(R) DCYL700 Fiber Optic Diffuser Series Flexible Fiber
Devices FDA
 HSMN NewsFeed - 4 Mar 2014
Neos Therapeutics Completes $15.5 Million Additional Series C Financing
Biopharmaceuticals Drug Delivery Venture Capital
 HSMN NewsFeed - 8 Jan 2014
Forest Laboratories to Acquire Aptalis for $2.9 Billion in Cash
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 30 Dec 2013
Concordia Healthcare Corp. announces filing of Ulesfia(R) with Health Canada
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Dec 2013
Concordia Healthcare Corp. Announces Acquisition Of Pinnacle Biologics, Inc.
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 22 Oct 2013
Neos Therapeutics, Inc. Announces the Appointment of Vipin K. Garg, Ph.D. as Chief Executive Officer and Board Director
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 3 Sep 2013
Aptalis Pharma(TM) Launches PYLERA(R) 10 Day Therapy PAK in the United States
Biopharmaceuticals Gastroenterology Product Launch
 HSMN NewsFeed - 15 Nov 2012
Tris Pharma Appoints New Vice President of Business Development
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 5 Dec 2011
Ampio Pharmaceuticals Announces Agreement to Acquire Key Drug Delivery Technology
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 14 Apr 2011
Mpex Pharmaceuticals, Inc. to be Acquired by Axcan
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 Jan 2011
U.S. FDA Approves Number One U.S.-Prescribed Allergy Treatment Allegra for Over-The-Counter Use
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Jan 2011
Eurand Announces Agreement With Nycomed for ZENPEP(R) in Russia-CIS
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 23 Jul 2010
Eisai Inc. and Pfizer Inc Announce U.S. FDA Approval for New Higher-Dose Aricept(R) (donepezil HCl) 23 mg Tablet for the Treatment of Moderate-to-Severe Alzheimer's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 7 Jul 2010
MonoSol Rx Announces FDA Approval of Zuplenz(R) Oral Soluble Film for Treatment of Nausea and Vomiting
Biopharmaceuticals Drug Delivery Oncology FDA
 HSMN NewsFeed - 17 Jun 2010
MonoSol Rx Appoints Dr. Mary Ellen Norvitch Vice President of Regulatory Affairs, Clinical Affairs and Quality Assurance
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 16 Jun 2010
Eurand Names Former Solvay Executive Jean-Louis Anspach President of U.S. Pharmaceuticals Business
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Nov 2009
Phase II/III Clinical Study Compares Safety and Efficacy of Two Doses of ZENPEP(TM) (Pancrelipase) Delayed-Release Capsules for Fat Absorption in Adult Chronic Pancreatitis Patients With Exocrine Pancreatic Insufficiency
Biopharmaceuticals
 HSMN NewsFeed - 10 Nov 2009
Teva Receives Favorable Court Decision Regarding Generic Prevacid(R) SoluTab
Biopharmaceuticals Generics Drug Delivery Litigation
 HSMN NewsFeed - 3 Nov 2009
FDA Approves New Salix Product Exclusively in Catalent's Zydis(R) Fast Dissolve Technology
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 8 Sep 2009
Salix Receives FDA Marketing Approval for METOZOLV ODT (Orally Disintegrating Tablets) for Relief of Diabetic Gastroparesis and Symptomatic Documented GERD
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 28 Aug 2009
Eurand Granted FDA Approval for ZENPEP(TM)
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Jun 2009
FDA Extends Review Period for Eurand's ZENPEP(TM) Pancreatic Enzyme Replacement Therapy
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 10 Jun 2009
Strativa's New Drug Application for Ondansetron Orally Dissolving Film Strip Accepted by FDA
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 11 May 2009
FDA Approves Lamictal(R) ODT(TM) Orally Disintegrating Tablets
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 11 May 2009
Eurand Announces FDA Approval of EUR-1048 (Lamictal(R) ODT(TM)), Co-Developed With GlaxoSmithKline
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 28 Apr 2009
Eurand Appoints Dr. Robert Becker as Chief Research Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Mar 2009
FDA Grants Orphan Drug Designation for EUR-1073
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 4 Feb 2009
Cephalon Appoints Sarma P. Duddu as General Manager and Vice President of Drug Delivery Technologies for CIMA LABS
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 29 Jan 2009
FDA Accepts Eurand's Response to Approvable Letter for EUR-1008 as Complete
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 Jan 2009
Azur Pharma Announces the Licensing of Niravam, Parcopa, Kemstro and Fluxid From UCB
Biopharmaceuticals Licensing
 HSMN NewsFeed - 25 Nov 2008
Watson Enters Into Agreement to Acquire Products Related to Teva's Proposed Acquisition of Barr
Biopharmaceuticals Acquisitions Generics
 HSMN NewsFeed - 22 Sep 2008
Mylan Receives FDA Approval for Generic Version of Parkinson's Treatment Parcopa(R) ODT
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 5 Sep 2008
Questcor Strengthens Management Team's Manufacturing and Commercial Operations Capabilities
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Feb 2008
U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Feb 2008
Sciele Expands Alliance with Sanofi-Aventis to Market Allegra(R) (Fexofenadine HCL) Orally Disintegrating Tablets (ODT) and Allegra(R) Oral Suspension (OS) in the U.S.
Biopharmaceuticals
 HSMN NewsFeed - 27 Dec 2007
U.S. District Court Decision About Eisai's Legal Action Over Aricept ODT(R) ANDA Filing
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 29 Nov 2007
Questcor Appoints Don M. Bailey as CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Nov 2007
Industry Veteran Timothy Saxon Joins Tris Pharma as Vice President, Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Nov 2007
Industry Veteran Timothy Saxon Joins Tris Pharma as Vice President, Business Development
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 15 Nov 2007
ABILIFY(R) (aripiprazole) Supplemental New Drug Application for the Treatment of Pediatric Patients with Bipolar I Disorder Accepted for Priority Review by the U.S. Food and Drug Administration
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Nov 2007
Questcor Appoints Stephen Farrell to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Nov 2007
U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for Adolescent Patients With Schizophrenia
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Sep 2007
Valeant Pharmaceuticals Announces the Launch of the zelaCARD for Parkinson's Disease Patients Taking Zelapar(R)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 17 Jul 2007
ABILIFY(R) (aripiprazole) Supplemental New Drug Application Receives Priority Review by U.S. Food And Drug Administration for Adjunctive Treatment in Adults With Major Depressive Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Jul 2007
Azur Pharma Announces the Acquisition of FazaClo for $42 Million Plus Contingent Milestones
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 26 Jun 2007
Teva Announces Approval of Ondansetron HCl Tablets and Ondansetron Orally Disintegrating Tablets USP
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 26 Jun 2007
KV Pharmaceutical Company Receives ANDA Approval for 4 mg. and 8 mg. Ondansetron Orally Disintegrating Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 25 Jun 2007
Mylan Announces Final FDA Approval for Ondansetron Hydrochloride Tablets and Ondansetron Orally Disintegrating Tablets, USP
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 31 May 2007
AVANIR Receives FDA Approval for New Formulation of Currently Marketed Antipsychotic Drug FazaClo
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Apr 2007
Ranbaxy Receives FDA Approval To Market Loratadine Antihistamine Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 26 Feb 2007
Mylan Announces Tentative FDA Approval for Ondansetron Orally Disintegrating Tablets, USP
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 30 Jan 2007
AVANIR Receives FDA Approvable Letter for New Formulation of Currently Marketed Antipsychotic Drug FazaClo
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Dec 2006
Par Pharmaceutical Receives Approval for Ondansetron Orally Disintegrating Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 20 Dec 2006
INVEGA(TM) Approved By FDA as New Treatment for Schizophrenia
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Dec 2006
ABILIFY(R) (Aripiprazole) Injection for Intramuscular Use for Adults With Agitation Associated With Schizophrenia or Bipolar Mania Now Available
Biopharmaceuticals
 HSMN NewsFeed - 7 Dec 2006
ABILIFY(R) (aripiprazole) Demonstrated Efficacy as Long-Term Maintenance Therapy in Adults With Bipolar I Disorder Following Treatment for a Recent Manic Or Mixed Episode
Biopharmaceuticals
 HSMN NewsFeed - 4 Dec 2006
Cephalon, Inc. Appoints Dr. Raj Khankari as General Manager of CIMA LABS
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Nov 2006
Barr Receives Tentative Approval for a Generic Version of ZYPREXA(R) Zydis(R) Tablets, 5mg, 10mg, 15mg and 20mg
Biopharmaceuticals FDA Generics
 HSMN NewsFeed - 28 Aug 2006
BioMarin Announces U.S. Launch of Orapred ODT Through Alliant Pharmaceuticals
Biopharmaceuticals
 HSMN NewsFeed - 17 Aug 2006
Bristol-Myers Squibb and Otsuka Pharmaceutical Company Launch New Rapidly Disintegrating Oral Antipsychotic Medication ABILIFY(R) DISCMELT(TM) (aripiprazole)
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 4 Aug 2006
Eisai Commences U.S. Legal Action Over Aricept ODT(R) ANDA Filing
Biopharmaceuticals Litigation
 HSMN NewsFeed - 18 Jul 2006
Valeant Pharmaceuticals Announces Availability of Zelapar(R) for Parkinson's Disease Patients
Biopharmaceuticals Drug Delivery Neurology
 HSMN NewsFeed - 15 Jun 2006
Valeant Pharmaceuticals Receives FDA Approval of Zelapar(R) for Patients with Parkinson's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 1 Jun 2006
BioMarin and Alliant Announce FDA Approval of Orapred ODT
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 15 Mar 2006
BioMarin and Alliant Pharmaceuticals Announce North American Licensing Agreement for Orapred
Biopharmaceuticals Licensing
Return to NewsFeed  

 Additional items found! 45

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 45 additional stories matching:
orally disintegrating tablet
(Password required)
FindReps 2 - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps 2 - available on the Apple App Store for iPhone and iPad.